Explaining Blood–Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms
Journal of Medicinal Chemistry · 08.06.2023 · 66 (11) · 7253-7267
DOI: 10.1021/acs.jmedchem.2c01824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 22.05.2023. Verfasst von Fleur M G Cornelissen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Amsterdam UMC, location VUMC, Cancer Center, Amsterdam 1105, AZ, the Netherlands. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Central Nervous System. Die Arbeit wurde bisher 142-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Brain Tumour Charity, Health~Holland, KWF Kankerbestrijding.
Abstract (Originalsprache)
The blood-brain barrier (BBB) represents a major obstacle to delivering drugs to the central nervous system (CNS), resulting in the lack of effective treatment for many CNS diseases including brain cancer. To accelerate CNS drug development, computational prediction models could save the time and effort needed for experimental evaluation. Here, we studied BBB permeability focusing on active transport (influx and efflux) as well as passive diffusion using previously published and self-curated data sets. We created prediction models based on physicochemical properties, molecular substructures, or their combination to understand which mechanisms contribute to BBB permeability. Our results show that features that predicted passive diffusion over membranes overlap with features that explain endothelial permeation of approved CNS-active drugs. We also identified physical properties and molecular substructures that positively or negatively predicted BBB transport. These findings provide guidance toward identifying BBB-permeable compounds by optimally matching physicochemical and molecular properties to BBB transport mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Amsterdam UMC, location VUMC, Cancer Center, Amsterdam 1105, AZ, the Netherlands.
- Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Rd, Cambridge CB2 1EW, U.K.
- Department of Pharmacy, Amsterdam UMC, location VUMC, Cancer Center, Amsterdam 1105, AZ, the Netherlands.
- Window Consortium (www.window-consortium.org).
ORCID-Profile: Greta Markert, Andreas Bender, Bart A Westerman
Förderung
- Brain Tumour Charity
- Health~Holland
- KWF Kankerbestrijding
- Innovation Exchange Amsterdam
Zitieren
APA
Cornelissen, F. M. G., Markert, G., Deutsch, G., Antonara, M., Faaij, N., Bartelink, I., Noske, D., Vandertop, W. P., Bender, A., & Westerman, B. A. (2023). Explaining Blood–Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms. Journal of Medicinal Chemistry, 66(11), 7253-7267. https://doi.org/10.1021/acs.jmedchem.2c01824
Vancouver
Cornelissen FMG, Markert G, Deutsch G, Antonara M, Faaij N, Bartelink I, et al. Explaining Blood–Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms. Journal of Medicinal Chemistry. 2023;66(11):7253-7267. doi:10.1021/acs.jmedchem.2c01824
BibTeX
@article{Cornelissen2023,
author = {Cornelissen, Fleur M G and Markert, Greta and Deutsch, Ghislaine and Antonara, Maria and Faaij, Noa and Bartelink, Imke and Noske, David and Vandertop, W Peter and Bender, Andreas and Westerman, Bart A},
title = {Explaining Blood–Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {11},
pages = {7253--7267},
doi = {10.1021/acs.jmedchem.2c01824}
}
EUVIMED